Autoliv Inc., operating through two principal subsidiaries Autoliv AB and Autoliv ASP, is one of the leading manufacturers and suppliers of a wide range of products, which majorly includes passive safety systems. Its passive safety systems include modules and components for frontal-impact & side-impact airbag protection systems, seatbelts, steering wheels, inflator technologies, battery cable cutters, pedestrian protection systems and child seats. Autoliv engages in joint ventures to expand geographical expansion, develop and gain support to market its full product line to vehicle manufacturers. Its business is conducted in five key regions, which includes Europe, the Americas, China, Japan and the Rest of Asia.'Major customers of this automotive safety supplier include Mitsubishi Motors, Nissan, Renault, Ford, Volkswagen, Hyundai, Kia, Honda, Toyota, Daimler, General Motors, BMW and Stellantis. It has two reportable segments: Airbags & Associated Products'and Seatbelts & Associated Products....
+See More2018-12-13 08:30:00 Thursday ET

The recent arrest of HuaWei senior executive manager may upend the trade truce between America and China. At the request of several U.S. authorities, Canadi
2020-06-24 09:32:00 Wednesday ET

Several business founders and entrepreneurs take low risks with high potential rewards to buck the conventional wisdom. Renee Martin and Don Martin (2010
2020-02-02 11:32:00 Sunday ET

Our fintech finbuzz analytic report shines fresh light on the current global economic outlook. As of Winter-Spring 2020, the analytical report delves into t
2022-02-22 09:30:00 Tuesday ET

The global asset management industry is central to modern capitalism. Mutual funds, pension funds, sovereign wealth funds, endowment trusts, and asset ma
2020-08-01 07:28:00 Saturday ET

Technological advances, geopolitical risks, and pandemic outbreaks cannot shake investor confidence in the American dollar as the global reserve currency.
2025-10-31 12:26:00 Friday ET

With respect to wider weight loss treatment and obesity treatment, the global market for GLP-1 medications now grows substantially to benefit more than 1 bi